Answers are grounded in this paper and cite their sources.
Compares transplant outcomes in patients with hematological malignancies and autoimmune diseases, indicating similar survival rates to controls.
Background and Objectives Patients with autoimmune diseases (ADs) are at an increased risk of developing hematological malignancies (HMs). While allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative option for HMs, the outcomes in patients with concomitant ADs and the effects of transplantation on autoimmune conditions remain poorly characterized. Methods In this real-world study, we compared transplantation outcomes between 41 patients with HMs and preexisting ADs and 123 matched controls with HMs but without ADs. Results A total of 65.8% of the patients with ADs had a disease duration of ≥ 3 years. All patients achieved hematological recovery. The AD group had a significantly higher incidence of chronic graft-versus-host disease (70.7% vs . 26.8%, P < 0.001). After a median follow-up of 24 (8–75) months, the 3-year overall survival (73.2% [95% CI: 60.2%–89.1%] vs . 76.3% [95% CI: 68.9%–84.4%], P = 0.76) and disease-free survival rates (68.8% [95% CI: 55.6%–85.3%] vs . 74.7% [95% CI: 67.2%–82.9%], P = 0.57) were comparable between the AD and control groups. No significant differences were observed in the 3-year cumulative incidence of relapse (7.7% [95% CI: 1.9%–18.8%] vs . 9.5% [95% CI: 5.0%–15.7%], P = 0.61) or nonrelapse mortality (23.5% [95% CI: 11.5%–38.0%] vs . 16.7% [95% CI: 10.6%–23.9%], P = 0.40). Multivariable analysis confirmed that preexisting AD was not an independent risk factor for survival, relapse, or nonrelapse mortality. Conclusions Our results suggest that allo-HSCT in patients with HMs and ADs is associated with survival outcomes that appear comparable to those in patients without ADs but also induces complete remission of AD in most patients.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: